Citius Oncology Inc.CTORNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-14.34%
↑ 47% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-27.21%
Historical baseline
PeriodValue
2025-14.34%
2024-69.72%
2023-24.79%
20220.00%